High density lipoprotein cholesterol and apolipoprotein A-I levels in 32–33-year-old women on steroid contraceptives—differences between two frequently used low-estrogen pills
- 1 October 1981
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 116 (2), 223-229
- https://doi.org/10.1016/0009-8981(81)90026-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?The Lancet, 1979
- Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.Circulation Research, 1978
- High-density lipoprotein cholesterol, monthly variation and association with cardiovascular risk factors in 1000 forty-year-old Dutch citizensClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- REDUCED HIGH-DENSITY LIPOPROTEIN IN WOMEN AGED 40-41 USING ORAL CONTRACEPTIVESThe Lancet, 1978
- The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart diseaseEuropean Journal of Clinical Investigation, 1978
- HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGENThe Lancet, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Quantitation of apolipoprotein A-I of human plasma high density lipoproteinMetabolism, 1976
- High density lipoproteins reduce the uptake of low density lipoproteins by human endothelial cells in cultureBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976